Union Health Ministry introduces bill to replace Pharmacy Council of India, invites comments Farhat Nasim16 Nov 2023 2:07 PM ISTNew Delhi: The Union Ministry of Health and Family Welfare has unveiled the proposed National Pharmacy Commission Bill for 2023, intending to...
NPPA fixes ceiling price of 9 Formulations, Details Dr. Divya Colin15 Nov 2023 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of 9 scheduled formulations under...
Akums Pharma gets CDSCO panel nod To Manufacture, Market FDC of doxylamine and pyridoxine Dr. Divya Colin14 Nov 2023 6:00 PM ISTNew Delhi: The drug major Akum Drugs and Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
Generate safety and efficacy data: CDSCO Tells Glenmark Over Glimipride, Lobeglitazone FDC Dr. Divya Colin13 Nov 2023 3:30 PM ISTNew Delhi: In response to the proposal presented by the drug major Glenmark Pharmaceuticals to conduct the Phase IV clinical trial of the fixed-dose...
Conduct Phase III clinical trial: CDSCO to Zydus Healthcare over FDC Empagliflozin plus Sitagliptin Dr. Divya Colin12 Nov 2023 4:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Zydus Healthcare, the Subject Expert Committee ( SEC) functional under the Central...
NPPA revises ceiling price of 438 scheduled formulation, Bare Metal Stents, details Dr. Divya Colin11 Nov 2023 4:00 PM ISTNew Delhi: In accordance with the price revision as per the annual wholesale price index (WPI) increase of 12.1218%, through a recent notification,...
FIRST: Takeda gets USFDA nod for Adzybm for rare inherited Blood Clotting Disorder Ruchika Sharma10 Nov 2023 11:39 AM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved ADZYNMA (ADAMTS13, recombinant-krhn) for the...
Novo Nordisk to discontinue long-acting insulin Levemir in US Ruchika Sharma9 Nov 2023 5:30 PM IST"Novo Nordisk will phase out, then permanently discontinue Levemir in the U.S. on December 31, 2024," the company said in a statement.
Revise Phase IV CT: CDSCO panel tells Bharat Biotech over Typhoid (Vi Capsular Polysaccharide) Tetanus Toxoid Conjugate Vaccine Dr. Divya Colin8 Nov 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has directed the vaccine maker...
Sun Pharma gets CDSCO nod to manufacture, market FDC Silodosin JP plus Tadalafil Dr. Divya Colin7 Nov 2023 5:30 PM ISTNew Delhi: Based on the Phase III Clinical trial (CT) of the Fixed Dose Combination (FDC) Silodosin JP plus Tadalafil presented by the drug major Sun...
Cadila's Cholecalciferol Aqueous Injection 6,00,000 IU/2ml exempted from price control: NPPA Written By Susmita Roy5 Nov 2023 5:30 PM ISTNew Delhi: Noting that Cadila Pharmaceutical's formulation "Cholecalciferol Aqueous Injection 6,00,000 IU/2ml (Vitamin D3 Injection)" was duly...
Submit raw data linked to CT result: CDSCO Panel Tells Akum Pharma on Azelnidipine, Metoprolol FDC drug Dr. Divya Colin4 Nov 2023 5:26 PM ISTNew Delhi: Based on the justification presented by Akum Pharmaceutical with respect to the clinical trial results of the fixed-dose combination...
